Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Interestingly, the great majority of individuals affected by the tumor have underlying liver disease, therefore narrowing the population to be screened. Still, however, there is a clear lack of blood biomarkers, and surveillance in those at risk is performed by frequent imaging of the liver. A variety of multinational collaborations are currently invested in finding biomarkers for HCC based on liver-produced proteins. A new approach with assessment of peripheral proteins might be necessary for the successful early detection of this malignancy.
Original language | English (US) |
---|---|
Pages (from-to) | 786-787 |
Number of pages | 2 |
Journal | Annals of Hepatology |
Volume | 18 |
Issue number | 6 |
DOIs |
|
State | Published - Nov 1 2019 |
Bibliographical note
Publisher Copyright:© 2019 Fundación Clínica Médica Sur, A.C.
Keywords
- Biomarkers
- Blood
- HCC